Until the world discovers a cure for cancer, each new treatment represents new hope.
Cancer clinical trials at Avera may open new doors for you and your loved ones by offering opportunities at the level of cancer screening, diagnosis and treatment. Oftentimes, these studies offer innovative options in addition to the current standard of care.
Led by John H. Lee, MD, FACS, Chief Medical Officer for Avera Cancer Research, our robust cancer research and clinical trials program ensures that you have access to the latest developments in cancer prevention, diagnosis and treatment.
Today’s patients benefit from Avera’s ever-expanding cancer research so that more people at more sites can receive the most cutting-edge options in cancer care while staying as close to home as possible.
To achieve this goal, we have disease-specific research staff who match patients to available clinical trials. Our research has expanded outside of Sioux Falls and Aberdeen to include locations in Pierre and Yankton, with the goal of offering cancer clinical trials at all six Avera Cancer Institute locations.
Cutting-Edge Cancer Research
When it comes to cancer care, most people understand the standard treatments: surgery, chemotherapy and radiation. Avera Cancer Research also offers cell therapies and immunotherapy treatments.
Cancer immunotherapy builds on the body’s natural immune response to recognize and remove cancer cells while also helping the immune system in various ways, such as blocking the immune system’s checkpoints to allow it to respond more strongly to cancer, or using immune cell therapy to selectively target cancer cells so they are more visible to the immune system.
We have the infrastructure in place to expand access to cutting-edge treatments through clinical trials, along with standard of care treatment plans. Examples include our work with precision oncology and our participation in many clinical trials.
Part of a Collaboration of Worldwide Genomics Experts
As part of a global consortium, Avera Cancer Institute joins others around the world with a shared goal: curing cancer through targeted therapies, based on the science of genomics.
Avera Cancer Institute is the fifth medical institution in the United States to join the Worldwide Innovative Networking (WIN) Consortium. The WIN Consortium is a global network of leading academic, industry, insurance and non-profit research organizations working to make personalized cancer care a reality for patients worldwide.
Clinical Trials for Innovative Cancer Treatment
You benefit from access to a variety of innovative clinical trial treatment options through the Avera Cancer Institute’s collaboration with industry sponsors and membership in NRG Oncology, which is one of four adult cancer groups sponsored by the National Cancer Institute.
Avera cancer research continues to expand across our footprint. You won’t need to travel far from home to receive the latest in cancer care, including a wide variety of clinical trials for:
- Screening and diagnosis
- Treatment for all stages of cancer including but not limited to:
- Genomic/precision therapy
- Cellular therapy
- Compassionate use and expanded access
Through collaboration with Avera’s FACT-accredited Transplant and Cellular Therapy team, the cancer research team is able to offer clinical trials utilizing cell therapy for treatment of patients with not only hematologic malignancies, but solid tumor cancers as well.